Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Product/R&D News
Sihuan Pharma's Self-Developed Anticancer Pirotinib Commenced Pha... (free) 8/14/2018
CBT Pharma Gets Ethics Approval for APOLLO-1 Phase 1/2 Trial for ... (free) 8/8/2018
MorphoSys and I-Mab Announce China IND Submission of mAb for MM 8/7/2018
Nobel Laureate to Launch Biomedicine Laboratory in Shenzhen 8/3/2018
Clover Biopharma Initiates Phase I Study of Etanercept Biosimilar... (free) 8/2/2018
Bio-Thera Initiates Phase I Trial for Biosimilar of Actemra (Toci... (free) 7/27/2018
CBT Pharma Initiates Phase 1b Trial for Anti-PD-1 Antibody Drug 7/26/2018
BeiGene Reports Progress of Pivotal Trial for Anti-PD-1 Antibody ... 7/24/2018
Xinhua: China's New Drug for Alzheimer's Completes Phase 3 Trial 7/17/2018
Sirona Biochem Announces CNDA Approval of SGLT2 Inhibitor for Pha... 7/12/2018
CStone's PD-1 Inhibitor CS1003 Gets Clinical Trial Approval in Ch... 7/12/2018
China Close to Approve Fruquintinib for Colon Cancer 7/3/2018
Page:4/4    Total number of articles:102  :[1][2][3][4]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links